BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1274590)

  • 1. Liver biopsies from psoriatics related to methotrexate therapy. 1. Findings in 123 consecutive non-methotrexate treated patients.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):253-61. PubMed ID: 1274590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
    Nyfors A; Poulsen H
    Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver biopsies from psoriatics related to methotrexate therapy. 3. Findings in post-methotrexate liver biopsies from 160 psoriatics.
    Nyfors A
    Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):511-8. PubMed ID: 899789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Malatjalian DA; Ross JB; Williams CN; Colwell SJ; Eastwood BJ
    Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of HL-A antigens to liver histology in methotrexate-treated psoriatics.
    Nyfors A; Svejgaard A
    Acta Derm Venereol; 1976; 56(3):235-8. PubMed ID: 59509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of methotrexate therapy in psoriatics on the Ito cells in liver biopsies, assessed by point-counting.
    Hopwood D; Nyfors A
    J Clin Pathol; 1976 Aug; 29(8):698-703. PubMed ID: 956451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
    Ashton RE; Millward-Sadler GH; White JE
    J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver biopsies from psoriatics treated with methotrexate.
    Ho MS; Cheah E; Tham SN; Teh LB; Ng HS; Thirumoorthy S
    Ann Acad Med Singap; 1986 Apr; 15(2):210-4. PubMed ID: 3752896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis.
    Nyfors A; Poulsen H
    Am J Surg Pathol; 1977 Sep; 1(3):235-43. PubMed ID: 920871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
    Themido R; Loureiro M; Pecegueiro M; Brandão M; Campos MC
    Acta Derm Venereol; 1992 Sep; 72(5):361-4. PubMed ID: 1361285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapy.
    Coulson IH; Mckenzie J; Neild VS; Joseph AE; Marsden RA
    Br J Dermatol; 1987 Apr; 116(4):491-5. PubMed ID: 3555595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis-liver-methotrexate interactions.
    Arch Dermatol; 1973 Jul; 108(1):36-42. PubMed ID: 4716740
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver disease in psoriatics--An effect of methotrexate therapy?
    Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
    Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis quantified by image analysis in methotrexate-treated patients with psoriasis.
    Nohlgård C; Rubio CA; Kock Y; Hammar H
    J Am Acad Dermatol; 1993 Jan; 28(1):40-5. PubMed ID: 7678843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.